Marc Peschanski, MD, PhD, Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I-Stem), Paris, France, explores limitations in implementing stem cell therapies into clinical practice as well as next steps to approach these challenges. This interview was recorded via an online conference call with The Video Journal of Regenerative Medicine (VJRegenMed).